Portable Patient Transport System (PPTS) Final

Questions & Answers / Clarifications

This document provides answers to questions submitted by potential offerors regarding the PPTS (Portable Patient Transfer System) opportunity, clarifying requirements and procurement details.

• Interoperability: Systems must be interoperable, with specific dimensional and interoperability requirements detailed in the SOO.
• Berry Amendment Compliance: Compliance is required. Prototypes must be Berry Compliant to avoid unacceptable costs and delays associated with re-testing if materials change between prototype and production.
• Cost Principles: As an Other Transaction (OT) agreement, it is not subject to FAR cost principles, but all proposed costs must be reasonable and directly allocable to the project.
• Partnering: Partnering is preferred and a foundational element of the acquisition strategy, especially involving Non-Traditional Defense Contractors (NDCs) and small businesses.
• Glove Ports & Pass-throughs: Specific requirements for glove port distance and number have been removed; focus is now on performance specifications. Alternative interface designs for pass-through ports (e.g., for vent tubes, IV lines) will be considered.
• Filtration: The requirement has been rewritten to specify a filter meeting or exceeding NIOSH HE HEPA-equivalent filtration performance (99.97% or greater at 0.3 microns).
• FDA Clearance: Solution Briefs must demonstrate a credible Phase III path to FDA clearance, even if clearance has not yet been initiated. Support for human factors engineering studies will be provided.
• Crash Testing: The system must be SAE J3027 crash-compliant for DOT vehicle transport.
• Waste Management: Alternative waste management approaches will be considered, provided they meet the 10-liter waste containment requirement.

Several requirements have been clarified or modified, including glove port specifications, filtration standards, and the approach to FDA clearance. Offerors should review these clarifications carefully when preparing their proposals. The final Call for Solutions (CFS)/SOO will be posted after April 1st, incorporating these answers.

Solicitation / RFP / RFQ

This Call for Solutions (CFS) seeks innovative prototype solutions for a Portable Patient Transport System (PPTS) under Other Transaction (OT) Agreement authority. The U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG), Natick Contracting Division (NCD) is procuring this system to support the Biocontainment, Isolation, and Quarantine (BIQ) PPTS program. The PPTS is intended for the safe, contained, and regulated transport of a single, non-ambulatory infectious patient via air, rail, ground, or sea, protecting personnel and platforms from biological threats while enabling medical care.

• System Functionality: Must control and prevent the spread of biological threats during transport.

• Certification: Must be certified for flight on multiple military airframes, compatible with select ambulances, and operable in austere environments.

• Performance Thresholds: Must meet specific requirements for negative pressure differential, airflow direction, air exchanges, filtration efficiency, and liquid containment (minimum 3 liters).

• Deliverables: Initial submission requires a "Solution Brief" (15 pages max) and a "Supporting Data Package." Follow-on submissions (RSP) will require a draft SOW, delivery schedule, firm-fixed-price, production rates, Bill of Materials (BOM), data rights assertions, and detailed performance documentation.

• Authority: 10 U.S.C. § 4022 (Prototype Projects).

• Agreement Type: Multiple Prototype Other Transaction (OT) Agreements.

• Phased Effort: Multi-phased acquisition strategy (Segments I, II, and potentially III) with down-selects.

• Follow-on Production: Potential for a non-competitive follow-on production award (up to 476 units over four years) upon successful completion.

• Initial Submission: Solution Brief and Supporting Data Package due by 03 June 2026, 1600 EST, via email.

• Evaluation: Solution Briefs will be evaluated on Technical Merit, Innovation & IP, and Affordability. Up to five offerors may be invited to submit a Request for Solution Proposal (RSP).

• RSP Evaluation: In-depth evaluation of technical approach, programmatic approach, and affordability.

• Segment I Award: Up to five OT agreements for initial system delivery (30 prototypes each).

• Segment II: Downselect to up to two performers for advanced integration and certification.

• Final Selection: Based on prototype performance, user feedback, affordability, and regulatory compliance.

• Non-Traditional Contractors/Small Businesses: Offerors must identify how they meet conditions under 10 U.S.C. § 4022(d)(1), focusing on significant participation from non-traditional defense contractors and/or small businesses.

• Intellectual Property: Government strongly prefers Unlimited Rights. Proposals hindering future sustainment competition may be evaluated negatively.

• Data Rights: Offerors must provide data rights assertions. Government Purpose Rights (GPR) or less may be evaluated negatively if they hinder competitive procurement.

• Cost Estimates: Rough Order of Magnitude (ROM) required for initial submission; firm-fixed-price and Life-Cycle Cost Estimate (LCCE) required for RSP.

• Attachments: Refer to the associated Statement of Objectives (SOO) for detailed performance requirements and test criteria.

Statement of Objectives (SOO)

This Statement of Objectives (SOO) seeks proposals for the development of a Portable Patient Transport System (PPTS) designed for single, non-ambulatory infectious patients. The system must enable controlled transport via air, rail, ground, or sea, preventing the spread of biological threats. It requires a man-portable system with a patient containment enclosure and an integrated, battery-powered air filtration system capable of maintaining negative pressure, sufficient air changes per hour (ACH), and filtering exhaust air.

The program is structured in two segments with multiple phases. Segment I involves delivering 30 prototype systems and demonstrating a minimum Technology Readiness Level (TRL) of 5. Down-selection will occur, with up to two performers proceeding to Segment II (Phases II and III). Segment II focuses on platform integration, environmental resilience, Reliability, Availability, and Maintainability (RAM) data collection, and airworthiness certification. A successful prototype must meet specific criteria including leak containment, force protection (negative pressure), head-to-foot airflow, 99.97% filtration efficiency, 12-hour continuous power operation, regulatory compliance (FDA marketing authorization), patient/crew interface capabilities, and airworthiness certification.

• Prototype Delivery: 30 systems for Segment I, 10 additional for Segment II.

• Technical Requirements: Leak containment (3L liquid), negative pressure (0.01 In.w.g), 12 ACH, 99.97% filtration, 12-hour battery life, compatibility with various transport platforms (NATO litter, ambulances), and airworthiness standards (MIL-HDBK-516).

• Data Deliverables: Regulatory Strategy, Test Support, Master Delivery Schedule, Bill of Materials, data rights assertions, safety documentation, manuals, and system support documentation.

• Regulatory: FDA marketing authorization is required by the end of Phase III.

• Awarded under 10 U.S.C. § 4022 (Phased Acquisition).

• Potential for a non-competitive follow-on production award of up to 476 units over four years for successful performers.

• Proposals must address all project segments and phases.

• Required proposal elements include a draft SOW, regulatory strategy, delivery schedule, total cost, projected production rate, BOM, data rights assertions, and supporting documentation for performance claims.

• Evaluation criteria include user feedback, prototype affordability, availability of funds, and test results.

• System development at performer facilities.

• Demonstrations and testing at CONUS Government facilities.

• The Government encourages novel and innovative concepts.

• Multiple submissions per performer are acceptable.

Questions & Answers / Clarifications

This document provides clarifications and answers to vendor questions regarding the solicitation for the PPTS (Portable Patient Transfer System).

• Glove Port Spacing: The distance between glove ports is defined in SOO, Table 2, with a center-to-center distance of no less than 33 cm and no greater than 43 cm.
• Number of Glove Ports: The requirement for fourteen total glove ports is listed under "Desired Requirements," not "Threshold Requirement."
• Transfer Pouch vs. Pass-Through Port: A transfer pouch is for item transfer while maintaining negative pressure; a pass-through port is for cabling or items like vent tubes, IV lines, and patient care devices.
• Berry Amendment Compliance: This is a statutory requirement (10 U.S.C. § 4862). While initial non-compliance with a promise of final compliance is not explicitly forbidden, it is highly discouraged due to testing replication costs. Prototypes should be Berry Compliant.
• Data Rights: The Government's strong preference is for Unlimited Rights. Proposals with less than Government Purpose Rights (GPR) may be evaluated negatively.
• Filter Location: Under Desired Requirements, both intake and exhaust filters should be located outside the containment enclosure.
• Filter Certification: HEPA-equivalent filtration (99.97% at 0.3 microns) is required. NIOSH P-100 is a threshold requirement, but other certifications meeting NIOSH criteria are acceptable.
• Stanchion Systems: The government does not have a specific NSN but provided specifications at: https://www.coemed.org/files/stanags/03_AMEDP/AMedP-2.1_EDA_V1_E_2040.pdf
• Affordability: Will be considered at all phases of the OTA.
• FDA Clearance: Solution briefs require demonstration of a credible Phase III path to FDA clearance; the actual clearance request is required by the end of Phase III.

These clarifications provide specific details on requirements, preferences, and compliance, which may influence vendor proposals and technical approaches. Bidders should ensure their proposals address these points, particularly regarding Berry Amendment compliance and data rights.

Other / Unclassified

This document provides the schedule for the JPM CBRN Protection Industry Day, specifically detailing the "1-1 Schedule." It outlines two groups, Group 1 and Group 2, with specific time slots and the companies that participated in one-on-one sessions during the event. The industry day focused on Biological Containment Isolation System (BCIS), Portable Patient Transport System (PPTS), and Shipboard Isolation System (SIS).

This document is relevant to potential bidders as it lists the companies that attended the industry day. This information can help vendors understand who else is interested in the JPM CBRN Protection opportunity and potentially identify partners or competitors. The schedule itself indicates the format of the industry day, which may provide context for future interactions or procurements related to BCIS, PPTS, and SIS.

Questions & Answers / Clarifications

This document provides responses to vendor questions regarding the solicitation for a system, likely related to bio-containment or patient isolation (referred to as PPTS, SIS, BCIS).

• Monitors: The system requires monitors for pressure loss alerts in both anteroom and main room.
• Glove Ports: The number and spacing of glove ports are based on user requirements and the need to prove adequate patient care capabilities.
• Pass-through vs. Pouch: Pass-through ports are for cabling, while pouches are for transferring items while maintaining negative pressure (e.g., food, medication).
• Berry Amendment: Compliance is required for prototypes. Non-compliant initial deliverables with a promise of final compliance are discouraged due to testing replication costs.
• Data Rights: The government prefers unlimited data rights; Government Purpose Rights are the minimum acceptable.
• FDA Clearance: A credible Phase III path to FDA clearance is acceptable for initial Solution Briefs, with clearance required by the end of Phase III. The government may provide support (funding, SMEs, data) for this process.
• Filtration: HEPA-equivalent filtration (99.97% at 0.3 microns) is required for exhaust filters. Preference is for filters in DoW inventory; carbon filters are not preferred.
• Weight Limits: Individual components must not exceed 50 lbs; the total system in stored configuration (including containers) must not exceed 200 lbs. SIS requires a 200 lb system threshold and 60 minutes of battery backup.
• Interoperability: Systems (SIS, PPTS) need to be interoperable within BCIS and on ships, and compatible with NATO litters.
• Quantities: Up to 15 systems are anticipated for the initial procurement.

These clarifications refine technical requirements, compliance expectations (e.g., Berry Amendment, FDA clearance), and operational details. Vendors should ensure their proposals address these points. The final Call for Solutions (CFS) and Statement of Objectives (SOO) will be updated based on these questions and answers.

Solicitation / RFP / RFQ

This Call for Solutions (CFS) W911QY-26-S-PPTS-01, issued by the U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG), Natick Contracting Division (NCD), seeks innovative solutions for a Portable Patient Transport System (PPTS). The PPTS is intended for the Biocontainment, Isolation, and Quarantine (BIQ) program to safely transport a single, non-ambulatory infectious patient via air, rail, ground, or sea, while preventing the spread of biological threats. The system must be certified for military airframes, operable in austere environments, and protect personnel and platforms from contamination.

• Core Functionality: Maintain negative pressure differential (0.01 inches of water gauge), head-to-foot airflow, 12 air exchanges per hour, and 99.97% filtration efficiency for 0.3-micron particles.

• Certification: Must be certified for flight on multiple military airframes and achieve FDA 510(k) clearance.

• Operational: Capable of 12 hours continuous operation, with less than 1-minute power interruption during battery hot swap. Must accommodate 5th to 95th percentile adult male and female dimensions for patient restraint.

• Containment: Must hold at least 3 liters of liquid contamination without leaking and allow item transfer while maintaining negative pressure.

• Integration: Compatible with NATO litters, specific ambulance models (UFM 82/83, AMBUS), and meet airworthiness requirements for various military aircraft (C-17, C-130, KC-135, HH-60).

• Deliverables: Initial submission requires a 15-page Solution Brief and a Supporting Data Package. Follow-on submissions may include a draft SOW, Master Delivery Schedule, Bill of Materials (BOM), cost estimates, and detailed test data.

• This effort is issued under the authority of 10 U.S.C. § 4022 against the Army Open Solicitation (AOS) W9128Z-25-S-A002 under BAA authority.

• The Government intends to award multiple Prototype Other Transaction (OT) Agreements.

• A phased acquisition strategy is planned, with potential for a non-competitive follow-on production contract for up to 400 units over four years upon successful completion.

• Initial Submission: Solution Brief (15 pages max) and Supporting Data Package (PDF format).

• Deadline: [DATE TBD] at 1600 EST.

• Evaluation: Submissions will be evaluated based on Technical Merit, Innovation & IP strategy, and Affordability. Subsequent phases will assess technical feasibility, integration potential, design maturity, and programmatic performance.

• The Government will assess whether offerors meet conditions under 10 U.S.C. § 4022(d)(1), with a focus on significant participation from non-traditional defense contractors and/or small businesses.

• The full Statement of Objectives (SOO) provides detailed performance requirements.

• The Government strongly prefers Unlimited Rights for all technical data, software, and intellectual property.

Statement of Objectives (SOO)

This Statement of Objectives (SOO) seeks proposals for the development of a Portable Patient Transport System (PPTS) to support the Biocontainment, Isolation, and Quarantine (BIQ) program. The system must enable the controlled transport of a single, non-ambulatory infectious patient by various means while preventing the spread of biological threats. The desired solution is a man-portable system with a patient containment enclosure and an integrated, battery-powered air filtration system.

This is a multi-phased prototype project awarded under 10 U.S.C. § 4022. The program consists of two segments:

• Segment I (Phase I): Up to five Other Transaction Agreements will be awarded. Performers will deliver 30 prototype systems and demonstrate a minimum TRL of 5 and MRL of 5. Down-selection to Segment II will be based on user feedback, affordability, funding availability, and test results.

• Segment II (Phases II & III): Up to two performers will proceed. Phase II focuses on platform integration and environmental testing (min TRL 6, MRL 6). Phase III focuses on airworthiness and operational flight testing (min TRL 8, MRL 8), culminating in Airworthiness Certification and FDA 510(k) clearance.

• System Functionality: Maintain negative pressure, provide sufficient air changes per hour (ACH), filter exhaust air (99.97% at 0.3-micron), control biological threats, and allow for continuous patient care via glove ports and pass-through interfaces.

• Performance Thresholds: Includes leak containment (3 liters), force protection (0.01 In.w.g negative pressure), 12 ACH, 12-hour continuous battery operation with hot-swap capability (<1 min interruption), FDA 510(k) clearance, compliance with MIL-STD-1472 for weight, and airworthiness requirements (MIL-HDBK-516).

• Deliverables: 30 prototype systems for Segment I, 10 additional prototypes for Segment II, and various data deliverables including a draft SOW, Master Delivery Schedule, Bill of Materials, test reports, safety documentation, and manuals.

Proposals must address all project segments and phases and include:

• Maturity level (TRL/MRL), production lead time, and total cost.
• A draft Statement of Work (SOW).
• Detailed Master Delivery Schedule.
• Total firm-fixed-price for prototypes.
• Projected unit cost and production rate for potential Full Rate Production.
• Complete Bill of Materials (BOM).
• Data rights assertions table.
• Supporting documentation for performance claims.
• Details on special logistical requirements.

Successful completion of this Other Transaction Authority (OTA) project may lead to a non-competitive follow-on production agreement for up to 400 units over four years.

System development at performer facilities. Demonstrations and testing at CONUS Government facilities post-award.